Cargando…

Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China

INTRODUCTION: Dolutegravir (DTG)-based regimen was included in the expanded formulary of China's National Free Antiretroviral Treatment Program at the end of 2021. Yet high price of DTG and lack of health economic evaluation in China present barriers for implementation of the regimen. The study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Cao, Yuxin, Huang, Hao, Qin, Gang, Chu, Minjie, Zou, Meiyin, Zhuang, Xun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641994/ https://www.ncbi.nlm.nih.gov/pubmed/37953277 http://dx.doi.org/10.1186/s12889-023-17052-1

Ejemplares similares

The Impact of Customized Short Message Service on High-Risk Behaviors Among MSM in China, a Randomized Controlled Trial Study
por: Huang, Hao, et al.
Publicado: (2023)

Analysis of hospitalization expenses of 610 HIV/AIDS patients in Nantong, China
por: Zhuang, Xun, et al.
Publicado: (2020)

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
por: Zhao, Shuai, et al.
Publicado: (2018)

Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China
por: Shen, Yinzhong, et al.
Publicado: (2015)

Association Between Prescription Cost Sharing and Adherence to Initial Combination Antiretroviral Therapy in Commercially Insured Antiretroviral-Naïve Patients with HIV
por: Johnston, Stephen S., et al.
Publicado: (2012)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children
por: Idris, Nikmah S., et al.
Publicado: (2016)

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children
por: Soto-Ramirez, Luis E., et al.
Publicado: (2010)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

The Prevalence of HIV-1 Drug Resistance among Antiretroviral Treatment Naïve Individuals in Mainland China: A Meta-Analysis
por: Su, Yingying, et al.
Publicado: (2014)

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
por: Alteri, Claudia, et al.
Publicado: (2009)

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran
por: Memarnejadian, Arash, et al.
Publicado: (2015)

Genetic characterization and antiretroviral resistance mutations among treatment-naive HIV-infected individuals in Jiaxing, China
por: Guo, Jinlei, et al.
Publicado: (2017)

HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania
por: Vairo, Francesco, et al.
Publicado: (2013)

Urinary biomarkers of early renal injury in antiretroviral‐naïve HIV‐positive persons in Shanghai, China: comparison with the general population
por: Le, XQ, et al.
Publicado: (2021)

Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand
por: Sungkanuparph, Somnuek, et al.
Publicado: (2012)

Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
por: Xiaobai, Zou, et al.
Publicado: (2014)

Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals
por: Zhuang, Yuchuan, et al.
Publicado: (2017)

Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan
por: Oka, Fukuko, et al.
Publicado: (2011)

Understanding the Role of Voluntary Counseling and Testing (VCT) in HIV Prevention in Nantong, China
por: Xu, Zhengcheng, et al.
Publicado: (2020)

Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China
por: Chen, Min, et al.
Publicado: (2012)

High Rate of Non-detectable HIV-1 RNA Among Antiretroviral Drug Naive HIV Positive Individuals in Nigeria
por: Odaibo, Georgina N, et al.
Publicado: (2013)

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2014)

HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia
por: Kotaki, Tomohiro, et al.
Publicado: (2015)

HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015
por: Avila-Ríos, Santiago, et al.
Publicado: (2016)

Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis
por: Guo, Chunxiang, et al.
Publicado: (2021)

HIV drug resistance and antiretroviral therapy programs in Henan, China-authors’ reply
por: Zuo, Lulu, et al.
Publicado: (2020)

Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals
por: Blanco-Heredia, Juan, et al.
Publicado: (2016)

Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya
por: Onywera, Harris, et al.
Publicado: (2017)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
por: Sinha, S., et al.
Publicado: (2012)

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
por: Budambula, Valentine, et al.
Publicado: (2015)

Efficacy of Efavirenz-Based Regimen in Antiretroviral-Naïve Patients with HIV-1 V179D/E Mutations in Shanghai, China
por: Wang, Zhenyan, et al.
Publicado: (2022)

HIV drug resistance and antiretroviral therapy programs in Henan, China
por: Liu, Zhi-Bin, et al.
Publicado: (2020)

Correction: Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals
por: Blanco-Heredia, Juan, et al.
Publicado: (2016)

Cost-effectiveness of dolutegravir vs. efavirenz-based combined antiretroviral therapies in HIV-infected treatment-naive patients in a Nigerian treatment centre
por: Isah, Abdulmuminu, et al.
Publicado: (2023)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

The prevalence of drug resistance among treatment-naïve HIV-1-infected individuals in China during pre- and post- 2004
por: Li, Hanping, et al.
Publicado: (2016)

Prevalence of Thrombocytopenia among Chinese Adult Antiretroviral-naïve HIV-positive Patients
por: Fan, Hong-Wei, et al.
Publicado: (2015)

Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
por: Lan, Yun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rrl079n037srdm3qqqvvcqldvc